These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence and clinical outcomes of non-endometrioid carcinoma of endometrium: Siriraj Hospital experience. Jaishuen A; Kunakornporamat K; Viriyapak B; Benjapibal M; Chaopotong P; Petsuksiri J; Therasakvichya S Asian Pac J Cancer Prev; 2014; 15(6):2905-9. PubMed ID: 24761923 [TBL] [Abstract][Full Text] [Related]
5. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis. Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis. Demopoulos RI; Mesia AF; Mittal K; Vamvakas E Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593 [TBL] [Abstract][Full Text] [Related]
7. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
8. Does the Increased Rate of Serous Component (≤25% vs. >25%) Increase Recurrence in Endometrial Cancer With Serous Plus Endometrioid Histology? Kaban A; Topuz S; Sozen H; Salihoglu Y J Obstet Gynaecol Can; 2019 Feb; 41(2):160-165. PubMed ID: 30316715 [TBL] [Abstract][Full Text] [Related]
9. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909 [TBL] [Abstract][Full Text] [Related]
10. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Matthews RP; Hutchinson-Colas J; Maiman M; Fruchter RG; Gates EJ; Gibbon D; Remy JC; Sedlis A Gynecol Oncol; 1997 May; 65(2):206-12. PubMed ID: 9159326 [TBL] [Abstract][Full Text] [Related]
11. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens? Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190 [TBL] [Abstract][Full Text] [Related]
12. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital. Prueksaritanond N; Chantape W J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019 [No Abstract] [Full Text] [Related]
14. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium. Holcomb K; Delatorre R; Pedemonte B; McLeod C; Anderson L; Chambers J Obstet Gynecol; 2002 Dec; 100(6):1290-5. PubMed ID: 12468176 [TBL] [Abstract][Full Text] [Related]
15. Papillary carcinoma of the endometrium: morphometric predictors of survival. Demopoulos RI; Genega E; Vamvakas E; Carlson E; Mittal K Int J Gynecol Pathol; 1996 Apr; 15(2):110-8. PubMed ID: 8786199 [TBL] [Abstract][Full Text] [Related]
16. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy. Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964 [TBL] [Abstract][Full Text] [Related]
17. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary? Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227 [TBL] [Abstract][Full Text] [Related]
18. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium. Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475 [TBL] [Abstract][Full Text] [Related]
19. Comparable outcome between endometrioid and non-endometrioid tumors in patients with early-stage high-grade endometrial cancer. Reynaers EA; Ezendam NP; Pijnenborg JM J Surg Oncol; 2015 May; 111(6):790-4. PubMed ID: 25900897 [TBL] [Abstract][Full Text] [Related]
20. Correlation between preoperative endometrial sampling and final endometrial cancer histology. Sany O; Singh K; Jha S Eur J Gynaecol Oncol; 2012; 33(2):142-4. PubMed ID: 22611951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]